46 results
8-K
EX-99.1
b1m1u xm1uf1z
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.2
2ag2p8 m9z
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.2
502tmuo z6l
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.2
3kbm4 jky4gntqajga
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.2
gkizzjb19bg72xyjb3
7 Jan 19
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:36am
8-K/A
EX-99.3
y7zecct21rpl 7dnm
25 Jun 18
Other Events
4:01pm
8-K
EX-99.3
ocw0jw2foic
21 Jun 18
Regulation FD Disclosure
8:11am